Showing results (81-90 of 579) with videos related to

Sort By:
Pageof 58
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1992
Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapyJ C Becker, R Dummer, A Schwinn, et al.
Archives of Dermatological Research|January 1, 1994
Influence of various cytokines on the interleukin-2-dependent lysis of melanoma cells in vitroE S Schultz, R Dummer, J C Becker, et al.
The Journal of Investigative Dermatology|July 1, 1993
Lesion-specific activation of cloned human tumor-infiltrating lymphocytes by autologous tumor cells: induction of proliferation and cytokine productionJ C Becker, A Schwinn, R Dummer, et al.
Seminars in Cutaneous Medicine and Surgery|July 13, 2000
Pathogenesis of cutaneous lymphomasR Dummer, J Willers, J Kamarashev, et al.
Clinical and Experimental Dermatology|June 15, 2005
HLA-G expression in basal cell carcinomas of the skin recurring after radiotherapyM Urosevic, W Kempf, B Zagrodnik, et al.
The British Journal of Dermatology|September 5, 2002
A case of Sézary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphomaP M Carrozza, W Kempf, D V Kazakov, et al.
The British Journal of Dermatology|March 5, 2004
Efficacy of laser treatment of tattoos using lasers emitting wavelengths of 532 nm, 755 nm and 1064 nmB M Prinz, S R Vavricka, P Graf, et al.
The British Journal of Dermatology|November 18, 2003
Imiquimod in basal cell carcinoma: how does it work?R Dummer, M Urosevic, W Kempf, et al.
Clinical and Experimental Immunology|January 1, 1993
Tumour-infiltrating lymphocytes in primary melanoma: functional consequences of differential IL-2 receptor expressionJ C Becker, A Schwinn, R Dummer, et al.
Dermatology (Basel, Switzerland)|January 1, 1997
Serum S100--a marker for disease monitoring in metastatic melanomaG Henze, R Dummer, H I Joller-Jemelka, et al.
Pageof 58